Protocol demonstrates improved neuropeptide detection in Rattus norvegicus brain tissue, highlighting the role of data-independent acquisition.
Endogenous neuropeptides are key modulators of brain function, playing critical roles in behavior, stress, pain, and homeostatic regulation, yet their analysis remains difficult. Biologically, they are low in abundance, rapidly degraded, and processed variably from precursor proteins, with expression limited to small, localized cell populations. Technically, their detection is complicated by a wide dynamic range, diverse post-translational modifications, and sparse signals in mass spectrometry datasets. This protocol outlines a comprehensive workflow for neuropeptide analysis in Rattus norvegicus brain tissue using both data-dependent acquisition (DDA) and data-independent acquisition (DIA) mass spectrometry (MS) on a timsTOF platform. Following optimized brain sample preparation, including dissection, peptide extraction and clean-up, nano liquid chromatography (LC)-MS is performed with ion mobility gas-phase fractionation to improve detection sensitivity and accuracy. The DDA-generated spectral library supports DIA-based quantification in Skyline, enabling high-confidence MS2-level measurements. This integrated workflow increases neuropeptide coverage and enhances quantitative reproducibility, providing a robust platform for studying neuropeptides in complex brain tissue.
No takes yet. Share an insight, caveat, or question.
Okyem et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: